Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Osteoporosis screening, HRT "reasonably cost-effective," OTA says.
Sep 11 1995
More from Archive
More from Medtech Insight